STATE-OF-THE-ART PAPER
Biomarkers in Acute Cardiac Disease
The Present and the Future
Allan S. Jaffe, MD*,*,
Luciano Babuin, MD* and
Fred S. Apple, PhD
* Division of Cardiovascular Diseases, Department of Medicine and the Department of Laboratory Medicine and Pathology, Mayo Clinic and Medical School, Rochester, Minnesota
Hennepin County Medicine Center and the University of Minnesota School of Medicine, Department of Laboratory Medicine and Pathology, Minneapolis, Minnesota
Manuscript received July 8, 2005;
revised manuscript received February 2, 2006,
accepted February 16, 2006.
* Reprint requests and correspondence: Dr. Allan S. Jaffe, Cardiovascular Division, Gonda 5, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905 (Email: jaffe.allan{at}mayo.edu).
The use of biomarkers to aid diagnosis and treatment is increasing rapidly as genomics and proteomics help us expand the number of markers we can use and as an improved understanding of the pathophysiology of cardiac disease guides their use. However, as with all rapidly expanding fields, there is the risk of excessive enthusiasm unless we are circumspect about the data that guide the clinical use of these new tools. This review focuses first on how to use troponin, which at present is the best validated of the new markers, and will hopefully provide insight into how to use this biomarker more productively by distinguishing subsets of patients and by providing an understanding of the meaning of elevations in various clinical situations. The review then discusses the use as well as the knowledge gaps associated with emerging biomarkers such as B-type natriuretic peptide and C-reactive protein, which are increasingly moving toward more productive clinical use. Finally, it reflects on some of the large number of markers that are still in development.
|
Abbreviations and Acronyms
| | ACS = acute coronary syndrome | | BNP = B-type natriuretic peptide | | CK = creatine kinase | | CRP = C-reactive protein | | cTn = cardiac troponin | | ECG = electrocardiogram | | ESRD = end-stage renal disease | | PCI = percutaneous coronary intervention |
|
This article has been cited by other articles:
|
|
|
|
 
F. S. Apple, S. W. Smith, L. A. Pearce, and M. M. Murakami
Assessment of the Multiple-Biomarker Approach for Diagnosis of Myocardial Infarction in Patients Presenting with Symptoms Suggestive of Acute Coronary Syndrome
Clin. Chem.,
January 1, 2009;
55(1):
93 - 100.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. Tanne, L. Kadem, R. Rieu, and P. Pibarot
Hemodynamic impact of mitral prosthesis-patient mismatch on pulmonary hypertension: an in silico study
J Appl Physiol,
December 1, 2008;
105(6):
1916 - 1926.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. Ravkilde
Markers in Cardiology: A Case-Orientated Approach. Jesse E. Adams, Fred S. Apple, and Allan S. Jaffe, editors. Malden, MA: Blackwell Futura Publishing, 2007, 261 pp, $99.95. ISBN 978-1-4051-3418-7.
Clin. Chem.,
December 1, 2008;
54(12):
2090 - 2091.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. K. Saenger and A. S. Jaffe
Requiem for a Heavyweight: The Demise of Creatine Kinase-MB
Circulation,
November 18, 2008;
118(21):
2200 - 2206.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Chatterjee, D. McGlothlin, and A. Michaels
Analytic Reviews: Cardiogenic Shock with Preserved Systolic Function: A Reminder
J Intensive Care Med,
November 1, 2008;
23(6):
355 - 366.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. S Alpert, K. Thygesen, A. Jaffe, and H. D White
The universal definition of myocardial infarction: a consensus document: Ischaemic heart disease
Heart,
October 1, 2008;
94(10):
1335 - 1341.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. V. G. Edwards, M. Y. White, and S. J. Cordwell
The Role of Proteomics in Clinical Cardiovascular Biomarker Discovery
Mol. Cell. Proteomics,
October 1, 2008;
7(10):
1824 - 1837.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. A.H. Stewart, O. C. Raffel, A. J. Kerr, R. Gabriel, I. Zeng, A. A. Young, and B. R. Cowan
Pilot Study to Assess the Influence of {beta}-Blockade on Mitral Regurgitant Volume and Left Ventricular Work in Degenerative Mitral Valve Disease
Circulation,
September 2, 2008;
118(10):
1041 - 1046.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Jaffe
Key Issues in the Developing Synergism between Cardiovascular Imaging and Biomarkers
Clin. Chem.,
September 1, 2008;
54(9):
1432 - 1442.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J. Pepine
Provoked Coronary Spasm and Acute Coronary Syndromes
J. Am. Coll. Cardiol.,
August 12, 2008;
52(7):
528 - 530.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. E. Head and P. Barash
Progress Is Precarious
Anesth. Analg.,
August 1, 2008;
107(2):
362 - 364.
[Full Text]
[PDF]
|
|
|
|
|
|
|
O. M. Gutierrez, H. Tamez, I. Bhan, J. Zazra, M. Tonelli, M. Wolf, J. L. Januzzi, Y. Chang, and R. Thadhani
N-terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) Concentrations in Hemodialysis Patients: Prognostic Value of Baseline and Follow-up Measurements
Clin. Chem.,
August 1, 2008;
54(8):
1339 - 1348.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P A Grayburn
How to measure severity of mitral regurgitation
Postgrad. Med. J.,
August 1, 2008;
84(994):
395 - 402.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. A. Carabello
The Current Therapy for Mitral Regurgitation
J. Am. Coll. Cardiol.,
July 29, 2008;
52(5):
319 - 326.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T Chung, W-C Lim, R Sy, I Cunningham, J Trotman, and L Kritharides
Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function
Heart,
July 1, 2008;
94(7):
911 - 918.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. S. Apple, S. W. Smith, L. A. Pearce, R. Ler, and M. M. Murakami
Use of the Centaur TnI-Ultra Assay for Detection of Myocardial Infarction and Adverse Events in Patients Presenting With Symptoms Suggestive of Acute Coronary Syndrome
Clin. Chem.,
April 1, 2008;
54(4):
723 - 728.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. A Grayburn
How to measure severity of mitral regurgitation
Heart,
March 1, 2008;
94(3):
376 - 383.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J Sanchis, X Bosch, V Bodi, N Bellera, J Nunez, B Benito, J Ordonez, L Consuegra, M Heras, and A Llecer
Combination of clinical risk profile, early exercise testing and circulating biomarkers for evaluation of patients with acute chest pain without ST-segment deviation or troponin elevation
Heart,
March 1, 2008;
94(3):
311 - 315.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U Ekelund and J L Forberg
New methods for improved evaluation of patients with suspected acute coronary syndrome in the emergency department
Postgrad. Med. J.,
February 1, 2008;
84(988):
83 - 86.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L Stefani, G Galanti, L Toncelli, P Manetti, M C Vono, M Rizzo, and N Maffulli
Bicuspid aortic valve in competitive athletes
Br. J. Sports Med.,
January 1, 2008;
42(1):
31 - 35.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. M. Larson, K. M. Menssen, S. W. Sharkey, S. Duval, R. S. Schwartz, J. Harris, J. T. Meland, B. T. Unger, and T. D. Henry
"False-Positive" Cardiac Catheterization Laboratory Activation Among Patients With Suspected ST-Segment Elevation Myocardial Infarction
JAMA,
December 19, 2007;
298(23):
2754 - 2760.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
U Ekelund and J L Forberg
New methods for improved evaluation of patients with suspected acute coronary syndrome in the emergency department
Emerg. Med. J.,
December 1, 2007;
24(12):
811 - 814.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Thygesen, J. S. Alpert, H. D. White, and on behalf of the Joint ESC/ACCF/AHA/WHF Task Force
Universal Definition of Myocardial Infarction
J. Am. Coll. Cardiol.,
November 27, 2007;
50(22):
2173 - 2195.
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Thygesen, J. S. Alpert, H. D. White, on behalf of the Joint ESC/ACCF/AHA/WHF Task Force, TASK FORCE MEMBERS: Chairpersons: Kristian Thygese, Biomarker Group: Allan S. Jaffe, Coordinator (USA), ECG Group: Bernard Chaitman, Co-ordinator (USA), P, Imaging Group: Richard Underwood, Coordinator (UK), Intervention Group: Jean-Pierre Bassand, Co-ordina, Clinical Investigation Group: Paul W. Armstrong, C, et al.
Universal Definition of Myocardial Infarction
Circulation,
November 27, 2007;
116(22):
2634 - 2653.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. K. Dunnick, K. A. Thayer, and G. S. Travlos
Inclusion of Biomarkers for Detecting Perturbations in the Heart and Lung and Lipid/Carbohydrate Metabolism in National Toxicology Program Studies
Toxicol. Sci.,
November 1, 2007;
100(1):
29 - 35.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Task Force Members, K. Thygesen, J. S. Alpert, H. D. White, Biomarker Group, A. S. Jaffe, F. S. Apple, M. Galvani, H. A. Katus, L. K. Newby, et al.
Universal definition of myocardial infarction: Kristian Thygesen, Joseph S. Alpert and Harvey D. White on behalf of the Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction
Eur. Heart J.,
October 2, 2007;
28(20):
2525 - 2538.
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. M. Bhaskar
Management of Venous Thromboembolism
Ann Intern Med,
October 2, 2007;
147(7):
519 - 520.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. Latif
Nonspecific Troponin Elevation
Arch Intern Med,
September 24, 2007;
167(17):
1906 - 1907.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
e1 - e157.
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. L. Anderson, C. D. Adams, E. M. Antman, C. R. Bridges, R. M. Califf, D. E. Casey Jr, W. E. Chavey II, F. M. Fesmire, J. S. Hochman, T. N. Levin, et al.
ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non ST-Elevation Myocardial Infarction) Developed in Collaboration with the American College of Emergency Physicians, the Society for Cardiovascular Angiography and Interventions, and the Society of Thoracic Surgeons Endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation and the Society for Academic Emergency Medicine
J. Am. Coll. Cardiol.,
August 14, 2007;
50(7):
652 - 726.
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. S. Apple and M. M. Murakami
Serum and Plasma Cardiac Troponin I 99th Percentile Reference Values for 3 2nd-Generation Assays
Clin. Chem.,
August 1, 2007;
53(8):
1558 - 1560.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. T. Ivandic, E. Spanuth, D. Haase, H.-G. Lestin, and H. A. Katus
Increased Plasma Concentrations of Soluble CD40 Ligand in Acute Coronary Syndrome Depend on in Vitro Platelet Activation
Clin. Chem.,
July 1, 2007;
53(7):
1231 - 1234.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. di Marco, S. Grendene, G. Feltrin, D. Meneghetti, and G. Gerosa
Antiplatelet therapy in patients receiving aortic bioprostheses: A report of clinical and instrumental safety
J. Thorac. Cardiovasc. Surg.,
June 1, 2007;
133(6):
1597 - 1603.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
NACB Writing Group Members, F. S. Apple, R. L. Jesse, L. K. Newby, A. H.B. Wu, and R. H. Christenson
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes
Circulation,
April 3, 2007;
115(13):
e352 - e355.
[Full Text]
[PDF]
|
|
|
|
|
|
|
NACB WRITING GROUP MEMBERS, F. S. Apple, R. L. Jesse, L. K. Newby, A. H.B. Wu, R. H. Christenson, NACB COMMITTEE MEMBERS, R. H. Christenson, F. S. Apple, C. P. Cannon, et al.
National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biochemical Markers of Acute Coronary Syndromes
Clin. Chem.,
April 1, 2007;
53(4):
547 - 551.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. A. Morrow and J. A. de Lemos
Benchmarks for the Assessment of Novel Cardiovascular Biomarkers
Circulation,
February 27, 2007;
115(8):
949 - 952.
[Full Text]
[PDF]
|
|
|
|
|
|
|
N. Nagajothi and A. Trivedi
Biomarkers in Acute Cardiac Disease
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2358 - 2358.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Jaffe, L. Babuin, and F. S. Apple
Reply
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2358 - 2359.
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. B. Fye
Troponin Trumps Common Sense
J. Am. Coll. Cardiol.,
December 5, 2006;
48(11):
2357 - 2358.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S. Jaffe
Chasing Troponin: How Low Can You Go if You Can See the Rise?
J. Am. Coll. Cardiol.,
November 7, 2006;
48(9):
1763 - 1764.
[Full Text]
[PDF]
|
|
|
|
